Global Pharmaceutical Gelatin Market by Types (Type A and Type B), Sources (Bovine Bone, Porcine, Poultry, Bovine Skin, and Marine), Applications (Tablets, Hard Capsules, Absorbable Hemostats, Soft Capsules, and Others), Functions (Thickening agents, Stabilizing agents, Gelling agents, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global pharmaceutical gelatin market size was valued at USD 1.2 billion in 2020 and is anticipated to reach USD 1.52 billion by 2028, expanding at a CAGR of 5.3% during the forecast period, 2021–2028. The growth of the market is attributed to rising need for gelatin capsules, due to increasing chronic illnesses, growing ageing population worldwide, rising developments, and changing trends in the healthcare and the pharmaceutical industry.
Pharmaceutical gelatin is delicate, translucent, colorless, and water-soluble food element with a high molecular weight, which is extracted from white connective tissues, skin, and bones of animals, by partial hydrolysis of collagen. Gelatin is used in a variety of pharmaceutical applications, as it is safe and absorbable. Gelatin coating on hard capsules, soft gel capsules, and tablets hide the odor of the medicine and make swallowing easy. Gelatin is a high-protein food that is used as a plasma substitute. Additionally, it is utilized as a suspending agent (helps maintain pharmaceutical suspensions stable) and in the production of capsules. Increased prevalence of COVID-19 fueled the demand for gelatin from the pharmaceutical industry all around the world. One of the primary factors that is expected to drive the market is the increasing use of gelatin in the food and beverage industry.
Market Trends, Drivers, Restraints, and Opportunities:
Drivers
- Growing demand for edible gelatin and its unique characteristics such as binding, gelling, coating, film-building, and adhesion in a variety of sectors around the world are anticipated to drive the global pharmaceutical gelatin market in the forecast period.
- Increasing R&D and technological advancements in the manufacture of cost-effective gelatin products are estimated to fuel the market in the coming years.
- Rising nutraceutical and pharmaceutical industries that use gelatin to manufacture drugs are projected to boost the market during the forecast period.
- Rising awareness regarding the importance of eating nutritious foods and increasing aging population across the globe are factors pushing the market expansion in the coming years.
Restraints
- High price of gelatin, which is heavily used in the outer covering of capsules, and the availability of substitute components are expected to hamper the market growth.
- Rising demand for plant-based pharmaceutical goods, due to increasing vegan population, and associated modifications in product portfolios by capsule producers are projected to hamper the market expansion.
Opportunities
- Growing need for pharmaceutical-grade gelatin in the emerging economy is estimated to create immense opportunities for the market players.
Global Market Segment Insights
Based on types, the market is divided into type A and type B. In the pharmaceutical gelatin market, the type B segment holds the highest share, due to increased preference for bovine bone for the manufacture of pharmaceutical gelatin and the cultural acceptance of bovine sources.
In terms of sources, the global pharmaceutical gelatin market is segregated into bovine bone, porcine, poultry, bovine skin, and marine. The porcine segment is expected to increase at a rapid rate. Rise of this segment is being fueled by factors such as its wide range of uses in the pharmaceutical industry, absorbable hemostats, and other biomedical applications, as well as low production costs and short manufacturing cycle.
On the basis applications, the market is segmented into tablets, hard capsules, absorbable hemostats, soft capsules, and others. The soft capsules segment is projected to represent a key share of the market during the forecast period, due to its benefits of being a patient-friendly dosage form with the potential to be formulated correctly for rapid or slow-release and a high degree of repeatability.
In terms of functions, the market is segregated into thickening agents, stabilizing agents, gelling agents, and others. The thickening agents’ segment is anticipated to dominate the market during the forecast period, due to its excessive use in medicinal syrups, elixirs, and other liquid dose forms.
Based on regions, the global primary cells market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. During the forecast period, the market in Asia Pacific is expected to grow at a significant CAGR. Key players are investing in this region, due to easy availability of porcine and bovine sources of raw material and low cost of labor and capital investment.
Segments
Segments Covered in the Report:By Types
- Type A
- Type B
- Bovine bone
- Porcine
- Poultry
- Bovine skin
- Marine
- Tablets
- Hard Capsules
- Absorbable Hemostats
- Soft Capsules
- Others
- Thickening agents
- Stabilizing agents
- Gelling agents
- Others
- Asia Pacific
- North America
- Europe, Latin America
- Middle East & Africa
- Nitta Gelatin Inc. (Japan)
- Darling Ingredients Inc. (US)
- Gelita AG (Germany)
- Tessenderlo Group (Belgium)
- Weishardt (France)
- India Gelatine & Chemicals Ltd. (India)
- Trobas Gelatine B.V. (Netherlands)
- Xiamen Gelken Gelatin Co. Ltd. (China)
- Lapi Gelatine S.p.A (Italy)
- Italgelatine S.p.A (Italy)
- Gelco International (Brazil)
- Aspire Pharmaceuticals. (US)
- Gelnex Industria E Comercio Ltda (Brazil)
Competitive Landscape
Major players in the global pharmaceutical gelatin market include Nitta Gelatin Inc. (Japan), Darling Ingredients Inc. (US), Gelita AG (Germany), Tessenderlo Group (Belgium), Weishardt (France), India Gelatine & Chemicals Ltd. (India), Trobas Gelatine B.V. (Netherlands), Xiamen Gelken Gelatin Co. Ltd. (China), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Gelco International (Brazil), Aspire Pharmaceuticals. (US), and Gelnex Industria E Comercio Ltda (Brazil).
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Gelatin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Gelatin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Gelatin Market - Supply Chain
4.5. Global Pharmaceutical Gelatin Market Forecast
4.5.1. Pharmaceutical Gelatin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Gelatin Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Gelatin Market Absolute $ Opportunity
5. Global Pharmaceutical Gelatin Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Types
5.3.1. Type A
5.3.2. Type B
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Pharmaceutical Gelatin Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
6.3.1. Tablets
6.3.2. Hard Capsules
6.3.3. Absorbable Hemostats
6.3.4. Soft Capsules
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Pharmaceutical Gelatin Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
8. North America Pharmaceutical Gelatin Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Types
8.4.1. Type A
8.4.2. Type B
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
8.7.1. Tablets
8.7.2. Hard Capsules
8.7.3. Absorbable Hemostats
8.7.4. Soft Capsules
8.7.5. Others
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
9. Latin America Pharmaceutical Gelatin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Types
9.4.1. Type A
9.4.2. Type B
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
9.7.1. Tablets
9.7.2. Hard Capsules
9.7.3. Absorbable Hemostats
9.7.4. Soft Capsules
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
10. Europe Pharmaceutical Gelatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Types
10.4.1. Type A
10.4.2. Type B
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
10.7.1. Tablets
10.7.2. Hard Capsules
10.7.3. Absorbable Hemostats
10.7.4. Soft Capsules
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
11. Asia Pacific Pharmaceutical Gelatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Types
11.4.1. Type A
11.4.2. Type B
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
11.7.1. Tablets
11.7.2. Hard Capsules
11.7.3. Absorbable Hemostats
11.7.4. Soft Capsules
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
12. Middle East & Africa Pharmaceutical Gelatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Types
12.4.1. Type A
12.4.2. Type B
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
12.7.1. Tablets
12.7.2. Hard Capsules
12.7.3. Absorbable Hemostats
12.7.4. Soft Capsules
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Pharmaceutical Gelatin Market: Market Share Analysis
13.2. Pharmaceutical Gelatin Distributors and Customers
13.3. Pharmaceutical Gelatin Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Nitta Gelatin Inc. (Japan)
13.4.2. Darling Ingredients Inc. (US)
13.4.3. Gelita AG (Germany)
13.4.4. Tessenderlo Group (Belgium)
13.4.5. Weishardt (France)
13.4.6. India Gelatine & Chemicals Ltd. (India)
13.4.7. Trobas Gelatine B.V. (Netherlands)
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Gelatin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Gelatin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Gelatin Market - Supply Chain
4.5. Global Pharmaceutical Gelatin Market Forecast
4.5.1. Pharmaceutical Gelatin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Gelatin Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Gelatin Market Absolute $ Opportunity
5. Global Pharmaceutical Gelatin Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Types
5.3.1. Type A
5.3.2. Type B
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Pharmaceutical Gelatin Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
6.3.1. Tablets
6.3.2. Hard Capsules
6.3.3. Absorbable Hemostats
6.3.4. Soft Capsules
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Pharmaceutical Gelatin Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Pharmaceutical Gelatin Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
8. North America Pharmaceutical Gelatin Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Types
8.4.1. Type A
8.4.2. Type B
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
8.7.1. Tablets
8.7.2. Hard Capsules
8.7.3. Absorbable Hemostats
8.7.4. Soft Capsules
8.7.5. Others
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
9. Latin America Pharmaceutical Gelatin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Types
9.4.1. Type A
9.4.2. Type B
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
9.7.1. Tablets
9.7.2. Hard Capsules
9.7.3. Absorbable Hemostats
9.7.4. Soft Capsules
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
10. Europe Pharmaceutical Gelatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Types
10.4.1. Type A
10.4.2. Type B
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
10.7.1. Tablets
10.7.2. Hard Capsules
10.7.3. Absorbable Hemostats
10.7.4. Soft Capsules
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
11. Asia Pacific Pharmaceutical Gelatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Types
11.4.1. Type A
11.4.2. Type B
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
11.7.1. Tablets
11.7.2. Hard Capsules
11.7.3. Absorbable Hemostats
11.7.4. Soft Capsules
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
12. Middle East & Africa Pharmaceutical Gelatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Types
12.4.1. Type A
12.4.2. Type B
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Pharmaceutical Gelatin Market Size and Volume Forecast by Applications
12.7.1. Tablets
12.7.2. Hard Capsules
12.7.3. Absorbable Hemostats
12.7.4. Soft Capsules
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Pharmaceutical Gelatin Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Pharmaceutical Gelatin Market: Market Share Analysis
13.2. Pharmaceutical Gelatin Distributors and Customers
13.3. Pharmaceutical Gelatin Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Nitta Gelatin Inc. (Japan)
13.4.2. Darling Ingredients Inc. (US)
13.4.3. Gelita AG (Germany)
13.4.4. Tessenderlo Group (Belgium)
13.4.5. Weishardt (France)
13.4.6. India Gelatine & Chemicals Ltd. (India)
13.4.7. Trobas Gelatine B.V. (Netherlands)
Segments Covered in the Report:
By Types
By Types
- Type A
- Type B
- Bovine bone
- Porcine
- Poultry
- Bovine skin
- Marine
- Tablets
- Hard Capsules
- Absorbable Hemostats
- Soft Capsules
- Others
- Thickening agents
- Stabilizing agents
- Gelling agents
- Others
- Asia Pacific
- North America
- Europe, Latin America
- Middle East & Africa
- Nitta Gelatin Inc. (Japan)
- Darling Ingredients Inc. (US)
- Gelita AG (Germany)
- Tessenderlo Group (Belgium)
- Weishardt (France)
- India Gelatine & Chemicals Ltd. (India)
- Trobas Gelatine B.V. (Netherlands)
- Xiamen Gelken Gelatin Co. Ltd. (China)
- Lapi Gelatine S.p.A (Italy)
- Italgelatine S.p.A (Italy)
- Gelco International (Brazil)
- Aspire Pharmaceuticals. (US)
- Gelnex Industria E Comercio Ltda (Brazil)
Major players in the global pharmaceutical gelatin market include Nitta Gelatin Inc. (Japan), Darling Ingredients Inc. (US), Gelita AG (Germany), Tessenderlo Group (Belgium), Weishardt (France), India Gelatine & Chemicals Ltd. (India), Trobas Gelatine B.V. (Netherlands), Xiamen Gelken Gelatin Co. Ltd. (China), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Gelco International (Brazil), Aspire Pharmaceuticals. (US), and Gelnex Industria E Comercio Ltda (Brazil).
Our Clients
Related Reports
Some other reports from this category!
